Skip to content
Search

Latest Stories

RPS celebrates ‘outstanding contributions to the pharmacy field’ with three new awards

An award has been created to honour RPS Fellow Nina Barnett,who played an instrumental part in developing the society's mentoring programme

 The Royal Pharmaceutical Society (RPS) announced three new awards – the Daniel Thomas Award, the OPERA Award and the Barnett Award – at its annual conference on Friday.


RPS President Professor Claire Anderson said each award recognises “exceptional contributions to the pharmacy field.”

The Daniel Thomas Award recognises pharmacists or pharmaceutical scientists who died while actively practising in the profession.

It is named after Daniel Thomas, a pharmacist who died during the First World War in 1917 while serving with the Royal Army Medical Corps.

The Outstanding Pharmacy Early-Career Researcher Award or OPERA Award recognises the achievements of early-career researchers within the pharmacy field.

The Barnett Award recognises those who have instilled a culture of excellence in mentoring and professional development.

It has been created to honour RPS Fellow Nina Barnett, who played an instrumental part in developing the RPS mentoring programme.

She dedicated her life to coaching and mentoring members of the healthcare family.

RPS Fellow Nina Barnett became the first winner of the Daniel Thomas Award.

Nina’s husband, Andre Ingram, who accepted the award on her behalf, said: “I am honoured to accept the Daniel Thomas Award on behalf of my wonderful wife, Nina.

“She would have wanted me to thank everyone she worked with who enabled her to excel at a career she loved.”

Stephen Kelly, a lecturer in pharmaceutical microbiomics at the Queen’s University Belfast School of Pharmacy, was presented the OPERA Award.

He is recognised for his research on microbiome analysis and its functional exploitation for pharmaceutical and healthcare applications.

Stephen said: “I am delighted to receive the 2023 OPERA prize in recognition of our research into the effects of the microbiome on health outcomes. This award reflects the hard work of various collaborative projects and highlights the impact of investigating such an important area of pharmacy research.”

Stephen also gave a presentation at the annual conference.

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less